This compound is a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients. It is a salt-like mixture containing an aromatic ring and carboxylic acid functional group, characterized by moderate polarity and lipophilicity.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2095311-49-0
Benzyl (3S,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
Pharmaceutical intermediate for synthesis
Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
pharmaceutical intermediate
Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo-(2,3-e)pyrazin-8-yl)pyrrolidine-1-carboxylate
pharmaceutical intermediate for API synthesis
MK-1026 Intermediate-Biayrl Ether
pharmaceutical intermediate
4-[(Acetyloxy)methyl]-5-methyl-1,3-dioxol-2-one
pharmaceutical intermediate
4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL)-1H-PYRAZOLE
Pharmaceutical intermediate
(3R,4S)-1-((Benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid
Pharmaceutical intermediate
Sulfoxonium, (2-((3R,4S)-4-ethyl-1-((phenylmethoxy)carbonyl)-3-pyrrolidinyl)-2-oxoethyl)dimethyl-, inner salt, rel-
Pharmaceutical intermediate for synthesis
N-cyclohexylcyclohexanamine;4-ethyl-1-phenylmethoxycarbonylpyrrolidine-3-carboxylic acid
XQYOTLNAUVFWHH-UHFFFAOYSA-N
CCC1CN(CC1C(=O)O)C(=O)OCC2=CC=CC=C2.C1CCC(CC1)NC2CCCCC2
—